A thiazolidinedione ("glitazone") for type 2 diabetes
Pioglitazone
A type 2 diabetes tablet that improves the body’s response to its own insulin — effective and without causing hypoglycaemia on its own, but it can cause fluid retention and weight gain.
What is Pioglitazone?
Pioglitazone lowers blood sugar in type 2 diabetes by making the body’s tissues more sensitive to insulin. On its own it does not cause low blood sugar (hypos). Its trade-offs are weight gain and fluid retention — so it is avoided in heart failure — and it needs some caution around bladder and bone health. It is taken once a day and works gradually.
Education and reference only. This is a plain-language guide to Pioglitazone — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Pioglitazone is a tablet for type 2 diabetes from the "glitazone" group. Rather than pushing the pancreas to make more insulin, it helps the body use its own insulin more effectively (reducing insulin resistance). It is usually added when other treatments such as metformin are not enough, and it can be combined with several other diabetes medicines. It is taken once daily and, like most diabetes tablets, works over weeks rather than instantly.
How it works
Pioglitazone activates a receptor (PPAR-gamma) inside fat, muscle and liver cells that controls how they respond to insulin and handle glucose and fats. The result is that these tissues take up glucose more readily and the liver releases less — lowering blood sugar. The same receptor’s effects on fat cells and salt handling explain its tendency to cause weight gain and fluid retention.
What it treats
Conditions Pioglitazone is used for
Practical use
How to take Pioglitazone
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- Take it once a day, with or without food, at a consistent time.
- Report swelling of the ankles, breathlessness, or rapid weight gain — these can signal fluid retention or heart strain.
- Report blood in the urine or new urinary symptoms promptly.
- Keep taking it consistently; the full effect on blood sugar takes several weeks to build.
- Attend diabetes and liver monitoring as advised.
Weighing it up
Advantages & disadvantages of Pioglitazone
Advantages
- Improves insulin sensitivity and, on its own, does not cause hypoglycaemia.
- Durable blood-sugar lowering that combines with most other diabetes medicines.
- Once-daily and low cost.
Disadvantages
- Causes fluid retention — avoided in heart failure — and weight gain.
- Small increased risks of bladder cancer and bone fractures.
- Works slowly, over weeks.
Practical use
Good to know
Pioglitazone does not cause hypoglycaemia on its own, which is an advantage, but it has some particular considerations. It causes the body to retain fluid, which can lead to swollen ankles and, importantly, can worsen or trigger heart failure — so it is not used in people with heart failure, and any breathlessness, swelling or rapid weight gain should be reported. It tends to cause weight gain. It has been linked to a small increase in the risk of bladder cancer and of bone fractures, so it is used with awareness of these; report blood in the urine. Its blood-sugar benefit builds up over weeks.
Who should not take it / use with caution
- People with heart failure, or a history of heart failure, because it causes fluid retention.
- People with active bladder cancer or unexplained blood in the urine, and with significant liver disease.
- Pregnancy and breastfeeding.
Monitoring
- Blood sugar control (HbA1c)
- Weight, and signs of fluid retention or heart failure
- Liver function; awareness of bladder symptoms
Side effects
- Common: weight gain and fluid retention (swollen ankles), and sometimes worsening of heart failure.
- An increased tendency to bone fractures, particularly in women.
- A small increased risk of bladder cancer — report blood in the urine; occasionally disturbed liver tests.
Key interactions
- Combining it with insulin or a sulfonylurea increases the risk of hypoglycaemia from those medicines, and adds to fluid-retention risk with insulin.
- Some medicines (such as gemfibrozil and rifampicin) change pioglitazone levels.
- Anti-inflammatory painkillers can add to fluid retention.
Available as: Tablets, including combination tablets with metformin.
Answers
Pioglitazone: frequently asked questions
Does pioglitazone cause low blood sugar?
Not on its own — because it improves how the body uses insulin rather than forcing out more, it does not usually cause hypos. The risk of hypos comes when it is combined with insulin or a sulfonylurea, in which case know the symptoms and how to treat a hypo.
Why can’t I take it if I have heart failure?
Pioglitazone makes the body hold on to fluid, which can overload a weak heart and worsen or trigger heart failure. For that reason it is avoided in anyone with heart failure or a history of it — report any new ankle swelling, breathlessness or rapid weight gain while taking it.
Why does it take so long to work?
Pioglitazone changes how cells respond to insulin, which builds up gradually — so the full effect on blood sugar can take several weeks to appear. Keep taking it consistently rather than expecting a quick change.
Should I worry about the bladder cancer risk?
The increase in risk is small, and pioglitazone is used when its benefits outweigh it. As a sensible precaution, report any blood in the urine or new urinary symptoms promptly so they can be checked, and your doctor will consider your individual risk before prescribing it.
Authoritative sources
- BNF: Pioglitazone.
- electronic Medicines Compendium (SmPC): Pioglitazone (Actos).
- NICE NG28: Type 2 diabetes in adults – management.
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.